EcoDrugPlus

Ensembl ID : ENSRFEG00010000531
Gene Symbol: HMGB1
1 Cross references
239 Possible Orthologues:

Ensembl ID : ENSRFEG00010019878
Gene Symbol: RPL39_1
1 Cross references
24 Possible Orthologues:

Ensembl ID : ENSRFEG00010008726
Gene Symbol: CACNG7
1 Cross references
253 Possible Orthologues:

Ensembl ID : ENSRFEG00010013864
Gene Symbol: RPL39_1
1 Cross references
20 Possible Orthologues:

Ensembl ID : ENSRFEG00010014922
Gene Symbol: RPL39_1
1 Cross references
22 Possible Orthologues:

Ensembl ID : ENSRFEG00010009790
Gene Symbol: RPS9
1 Cross references
219 Possible Orthologues:

Ensembl ID : ENSRFEG00010008547
Gene Symbol: PRKCG
1 Cross references
198 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSRFEG00010000532
Gene Symbol: DHCR24
1 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSRFEG00010013017
Gene Symbol: HMGCR
1 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSRFEG00010021827
Gene Symbol: PDPK1
1 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSRFEG00010006225
Gene Symbol: HPD
1 Cross references
204 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSRFEG00010000563
Gene Symbol: NT5E
1 Cross references
249 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).